Research Site

Trento 38100

1 studies enrolling now · 5 studies all time

What they study most

Anemia, Breast Cancer, Early Breast Cancer, Cardiovascular Disease, Congestive Heart Failure, Heart Failure, Metastatic Castration-Sensitive Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Non-small Cell Lung Cancer, Ventricular Dysfunction

Studies at this site

• An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) — Recruiting now
• Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents — Running, not enrolling
• Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study) — Completed
• RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial — Completed
• Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START) — Completed